Genomics & Informatics

Korea Genome Organization (한국유전체학회)
권호 표지

An RNA Mapping Strategy to Identify Ribozyme-Accessible Sites on the Catalytic Subunit of Mouse Telomerase

  • Song, Min-Sun (Department of Molecular Biology, BK21 Graduate Program for RNA Biology, Institute of Nanosensor and Biotechnology, Dankook University) ;
  • Lee, Seong-Wook (Department of Molecular Biology, BK21 Graduate Program for RNA Biology, Institute of Nanosensor and Biotechnology, Dankook University)
  • Published : 2007.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Telomerase reverse transcriptase (TERT) is an enzymatic ribonucleoprotein that prolongs the replicative life span of cells by maintaining protective structures at the ends of eukaryotic chromosomes. Telomerase activity is highly up-regulated in 85-90% of human cancers, and is predominately regulated by hTERT expression. In contrast, most normal somatic tissues in humans express low or undetectable levels of telomerase activity. This expression profile identifies TERT as a potential anticancer target. By using an RNA mapping strategy based on a trans-splicing ribozyme library, we identified the regions of mouse TERT (mTERT) RNA that were accessible to ribozymes. We found that particularly accessible sites were present downstream of the AUG start codon. This mTERTspecific ribozyme will be useful for validation of the RNA replacement as cancer gene therapy approach in mouse model with syngeneic tumors.

Keywords

References

  1. Bodnar, A.G., Ouellette, M., Frolkis, M., Holt, S.E., Chiu, C.P., Morin, G.B., Harley, C.B., Shay, J.W., Lichtsteiner, S., and Wright, W.E. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352 https://doi.org/10.1126/science.279.5349.349
  2. Greenberg, R.A., Allsopp, R.C., Chin, L., Morin, G.B., and DePinho, R.A. (1998). Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16, 1723-1730 https://doi.org/10.1038/sj.onc.1201933
  3. Hahn, W.C., Counter, C.M., Lundberg, A.S., Beijersbergen, R.L., Brooks, M.W., and Weinberg, R.A. (1999). Creation of human tumor cells with defined genetic elements. Nature 400, 464-468 https://doi.org/10.1038/22780
  4. Jaeger, J., Turner, D., and Zuker, M. (1989). Improved predictions of secondary structures for RNA. Proc. Natl. Acad. Sci. USA 86, 7706-7710
  5. Jones, J.T., Lee, S.W., and Sullenger, B.A. (1996). Tagging ribozyme reaction sites to follow trans-splicing in mammalian cells. Nature Med. 2, 643-648 https://doi.org/10.1038/nm0696-643
  6. Kwon, B.S., Jung, H.S., Song, M.S., Cho, K.S., Kim, S.C., Kimm, K., Jeong, J.S., Kim, I.H., and Lee, S.W. (2005). Specific regression of human cancer cells by ribozyme-mediated targeted replacement of tumor-specific transcript. Mol. Ther. 12, 824-834 https://doi.org/10.1016/j.ymthe.2005.06.096
  7. Lan, N., Howrey, R.P., Lee, S.-W, Smith, C.A., and Sullenger, B.A. (1998). Ribozyme-mediated repair of sickle ${\beta}$-globin mRNAs in erythrocyte precursors. Science 280, 1593-1596 https://doi.org/10.1126/science.280.5369.1593
  8. Lan, N., Rooney, B.L., Lee, S.W., Howrey, R.P., Smith, C.A., and Sullenger, B.A. (2000). Enhancing RNA repair efficiency by combining trans-splicing ribozymes that recognize different accessible sites on a target RNA. Mol. Ther. 2, 245-255 https://doi.org/10.1006/mthe.2000.0125
  9. Long, M.B., Jones, J.P. 3rd, Sullenger, B.A., and Byun, J. (2003). Ribozyme-mediated revision of RNA and DNA. J. Clin. Invest. 112, 312-318 https://doi.org/10.1172/JCI200319386
  10. Newbold, R.F. (1997). Genetic control of telomerase and replicative senescence in human and rodent cells. Ciba. Found. Symp. 211, 177-189
  11. Ryu, K.J., Kim, J.H., and Lee, S.W. (2003). Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing. Mol. Ther. 7, 386-395 https://doi.org/10.1016/S1525-0016(02)00063-1
  12. Shay, J.W. and Bacchetti, S. (1997). A survey of telomerase activity in human cancer. Eur. J. Cancer 33, 787-791 https://doi.org/10.1016/S0959-8049(97)00062-2
  13. Shi, H.Y., Zhang, W., Liang, R., Abraham, S., Kittrell, F.S., Medina, D., and Zhang, M.(2001). Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Res. 61, 6945-6951
  14. Song, M.S. and Lee, S.W. (2006). Cancer-selective induction of cytotoxicity by tissue-specific expression of targeted trans-splicing ribozyme. FEBS Lett. 580, 5033-5043 https://doi.org/10.1016/j.febslet.2006.08.021
  15. Sullenger, B.A. (1995). Revising messages traveling along the cellular information highway. Chem. Biol. 2, 249-253 https://doi.org/10.1016/1074-5521(95)90043-8
  16. Sullenger, B.A. and Cech, T. R. (1994). Ribozyme-mediated repair of defective mRNA by targeted trans-splicing. Nature 317, 619-622
  17. Wang, J., Hannon, G.J., and Beach, D.H. (2000). Risky immortalization by telomerase. Nature 405, 755-756 https://doi.org/10.1038/35015674
  18. Weitzman, J.B. and Yaniv, M. (1999). Rebuilding the road to cancer. Nature 400, 401-402 https://doi.org/10.1038/22637